MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
339
Unique beneficiaries
—
Total services
8,835
Distinct HCPCS
12
Medicare payment
$383K
Peer benchmark
Total Medicare services vs. 272 Allergy/ Immunology providers in NY — top quintile (cohort median 2,067).
PRESCRIBING · PART D · 2024
Total Rx claims
370
Beneficiaries
—
Total drug cost
$99K
Distinct drugs
14
Brand share
28.6%
Top prescribed drugs
Prednisone59 claims
Montelukast Sodium57 claims
Fluticasone Propionate37 claims
Levocetirizine Dihydrochloride30 claims
Albuterol Sulfate25 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$475
Payment records
16
By payment type
Food and Beverage$409
Education$66
Top paying entities
Food and Beverage$409
Education$66
REFERRAL NETWORK
Where Ma. Lourdes De Asis's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 6 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| John Bosso Allergy/ Immunology · Philadelphia, PA | 29 | 64 |
| Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ | 15 | 52 |
| MONTEFIORE NYACK HOSPITAL | 14 | 39 |
| Bioreference Health, Llc Clinical Laboratory · Elmwood Park, NJ | 13 | 47 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| Quest Diagnostics Incorporated Clinical Laboratory · Clifton, NJ | 35 | 167 |
| John Bosso Allergy/ Immunology · Philadelphia, PA | 32 | 84 |
| SHIEL HOLDINGS LLC | 14 | 43 |
| Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ | 12 | 50 |
| MONTEFIORE NYACK HOSPITAL | 11 | 43 |
| Bioreference Health, Llc Clinical Laboratory · Elmwood Park, NJ | 11 | 63 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE